Abstract
Background: COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents a broad spectrum of clinical manifestations, ranging from mild symptoms to severe conditions requiring intensive care. Beyond its well-known respiratory complications, COVID-19 has been increasingly associated with various immune and hematological complications, including cases of hemolytic anemia. This report adds to the emerging evidence linking COVID-19 to hematological abnormalities, specifically nonimmune mediated hemolytic anemia (NIHA).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
